vTv Therapeutics Inc.
VTVT
$21.96
-$0.78-3.43%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 1.00M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 1.00M | -- | -- |
| Cost of Revenue | 3.22M | 217.00K | 2.65M | 2.14M | 2.82M |
| Gross Profit | -3.22M | -217.00K | -1.65M | -2.14M | -2.82M |
| SG&A Expenses | 3.28M | 3.72M | 3.98M | 2.57M | 2.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.51M | 7.16M | 6.63M | 4.71M | 5.37M |
| Operating Income | -6.51M | -7.16M | -5.63M | -4.71M | -5.37M |
| Income Before Tax | -5.84M | -6.41M | -5.92M | -4.44M | -8.54M |
| Income Tax Expenses | -- | -- | 100.00K | -- | -- |
| Earnings from Continuing Operations | -5.84M | -6.41M | -6.02M | -4.44M | -8.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.06M | 1.23M | 1.15M | 963.00K | 1.89M |
| Net Income | -4.78M | -5.18M | -4.87M | -3.48M | -6.65M |
| EBIT | -6.51M | -7.16M | -5.63M | -4.71M | -5.37M |
| EBITDA | -6.48M | -7.13M | -5.61M | -4.68M | -5.35M |
| EPS Basic | -1.83 | -2.13 | -2.00 | -1.67 | -3.19 |
| Normalized Basic EPS | -0.99 | -1.14 | -1.05 | -0.87 | -1.66 |
| EPS Diluted | -1.83 | -2.13 | -2.00 | -1.67 | -3.19 |
| Normalized Diluted EPS | -0.99 | -1.14 | -1.05 | -0.87 | -1.66 |
| Average Basic Shares Outstanding | 2.61M | 2.43M | 2.43M | 2.09M | 2.09M |
| Average Diluted Shares Outstanding | 2.61M | 2.43M | 2.43M | 2.09M | 2.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
